These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 3947646)

  • 1. Inhibition of mammalian glyoxalase I (lactoylglutathione lyase) by N-acylated S-blocked glutathione derivatives as a probe for the role of the N-site of glutathione in glyoxalase I mechanism.
    Al-Timari A; Douglas KT
    Biochim Biophys Acta; 1986 Mar; 870(1):160-8. PubMed ID: 3947646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the N-terminus of glutathione in the action of yeast glyoxalase I.
    Douglas KT; Al-Timari A; D'Silva C; Gohel DI
    Biochem J; 1982 Nov; 207(2):323-29. PubMed ID: 7159385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH Dependence of the inhibition of yeast glyoxalase I by porphyrins.
    Douglas KT; Sharif JG
    Biochim Biophys Acta; 1983 Oct; 748(2):184-93. PubMed ID: 6354270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence and nuclear relaxation enhancement studies of the binding of glutathione derivatives to manganese-reconstituted glyoxalase I from human erythrocytes. A model for the catalytic mechanism of the enzyme involving a hydrated metal ion.
    Sellin S; Eriksson LE; Mannervik B
    Biochemistry; 1982 Sep; 21(20):4850-7. PubMed ID: 7138835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of the competitive inhibitor S-(p-bromobenzyl)-glutathione to glyoxalase I from yeast.
    Marmstal E; Mannervik B
    FEBS Lett; 1979 Jun; 102(1):162-4. PubMed ID: 378697
    [No Abstract]   [Full Text] [Related]  

  • 6. Inactivation of glyoxalase I from porcine erythrocytes and yeast by amino-group reagents.
    Mannervik B; Marmstål E; Ekwall K; Górna-Hall B
    Eur J Biochem; 1975 May; 53(2):327-33. PubMed ID: 237756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial transition-state inhibitors of glyoxalase I from human erythrocytes, yeast and rat liver.
    Douglas KT; Gohel DI; Nadvi IN; Quilter AJ; Seddon AP
    Biochim Biophys Acta; 1985 May; 829(1):109-18. PubMed ID: 3888271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of the reaction catalyzed by glyoxalase I. Calculation of the equilibrium constant for the enzymatic reaction.
    Sellin S; Mannervik B
    J Biol Chem; 1983 Jul; 258(14):8872-5. PubMed ID: 6863314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QSAR of the inhibition of glyoxalase by S-substituted glutathiones.
    Silipo C; Hansch C
    Farmaco Sci; 1979 Jan; 34(1):3-10. PubMed ID: 553818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the active site of glyoxalase I from human erythrocytes by use of the strong reversible inhibitor S-p-bromobenzylglutathione and metal substitutions.
    Aronsson AC; Sellin S; Tibbelin G; Mannervik B
    Biochem J; 1981 Jul; 197(1):67-75. PubMed ID: 7317034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reinvestigation of the roles of the carboxyl groups of glutathione with yeast glyoxalase I. Implications as to the mechanism and coenzymic role of glutathione.
    D'Silva C
    FEBS Lett; 1986 Jul; 202(2):240-4. PubMed ID: 3522272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by glutathione derivatives of bovine liver glyoxalase II (hydroxyacylglutathione hydrolase) as a probe of the N- and S-sites for substrate binding.
    Al-Timari A; Douglas KT
    Biochim Biophys Acta; 1986 Mar; 870(2):219-25. PubMed ID: 3955057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-(N-aryl-N-hydroxycarbamoyl)glutathione derivatives are tight-binding inhibitors of glyoxalase I and slow substrates for glyoxalase II.
    Murthy NS; Bakeris T; Kavarana MJ; Hamilton DS; Lan Y; Creighton DJ
    J Med Chem; 1994 Jul; 37(14):2161-6. PubMed ID: 8035422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of glyoxalase I by the enediol mimic S-(N-hydroxy-N-methylcarbamoyl)glutathione. The possible basis of a tumor-selective anticancer strategy.
    Hamilton DS; Creighton DJ
    J Biol Chem; 1992 Dec; 267(35):24933-6. PubMed ID: 1459997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yeast glyoxalase I. Circular dichroic spectra and pH effects.
    Douglas KT; Seddon AP; Nakagawa Y
    Int J Biochem; 1986; 18(6):549-55. PubMed ID: 3519311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and kinetic evaluation of S- and N-substituted cysteinylglycines as inhibitors of glyoxalase I.
    Lyon PA; Vince R
    J Med Chem; 1977 Jan; 20(1):77-88. PubMed ID: 833829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simplified method for the purification of human red blood cell glyoxalase. I. Characteristics, immunoblotting, and inhibitor studies.
    Allen RE; Lo TW; Thornalley PJ
    J Protein Chem; 1993 Apr; 12(2):111-9. PubMed ID: 8489699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical modification of tyrosine residues in glyoxalase I from yeast and human erythrocytes.
    Carrington SJ; Fetherbe D; Douglas KT
    Int J Biochem; 1989; 21(8):901-8. PubMed ID: 2684702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and activity of gamma-(L-gamma-azaglutamyl)-S-(p-bromobenzyl)-L-cysteinylglycine: a metabolically stable inhibitor of glyoxalase I.
    Vince R; Brownell J; Akella LB
    Bioorg Med Chem Lett; 1999 Mar; 9(6):853-6. PubMed ID: 10206549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of S-(p-bromobenzyl)glutathione diesters in vitro: a structure-activity study.
    Thornalley PJ; Ladan MJ; Ridgway SJ; Kang Y
    J Med Chem; 1996 Aug; 39(17):3409-11. PubMed ID: 8765525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.